Chairman of The First Affiliated Hospital Zhejiang University, China.
Prof. Liang Tingbo, MD, PhD, is a distinguished leader in hepatobiliary and pancreatic surgery and liver transplantation, currently serving as Chairman at The First Affiliated Hospital, Zhejiang University. With a robust academic background, including a PhD from Zhejiang University, Prof. Liang has made substantial contributions to his field through over 400 published articles on liver cancer and transplantation. His research is supported by more than 50 major grants from national and provincial funding bodies. Recognized for his excellence, he has received prestigious awards such as the Yangtze River Scholar and National Distinguished Young Scholar. His extensive leadership roles in various medical associations and editorial boards further underscore his global impact. Prof. Liang’s work not only advances medical science but also reflects a commitment to improving patient outcomes and driving innovation in his specialty.
Prof. Liang Tingbo’s academic journey showcases a strong foundation in medicine and surgery. He earned his Ph.D. from the School of Medicine at Zhejiang University in 2002, focusing on advanced medical research. Prior to this, he completed his Master’s degree at the same institution in 1992, where he began to build his expertise in hepatobiliary and pancreatic surgery. His education at Zhejiang University laid the groundwork for his future contributions in the field. This rigorous academic background, coupled with extensive practical experience, has positioned Prof. Liang as a leading figure in his specialization, contributing significantly to research and clinical practice in liver transplantation and pancreatic diseases. His education reflects a deep commitment to advancing medical science and demonstrates a consistent trajectory of academic excellence and professional development throughout his career.
Prof. Liang Tingbo exhibits exceptional research skills in the field of hepatobiliary and pancreatic surgery and liver transplantation. His expertise encompasses advanced techniques in tumor microenvironment analysis, pancreatic cancer research, and liver transplantation. Prof. Liang excels in integrating multi-omic approaches to uncover tumor heterogeneity and immunophenotypic classifications, as evidenced by his influential publications in leading journals. His proficiency in securing substantial research funding demonstrates his ability to design and lead complex studies, including those involving novel nanoparticle delivery systems and regulatory T cells in liver transplantation. His skills extend to collaborative research, as seen through his numerous roles on editorial boards and as a reviewer for prestigious journals. Prof. Liang’s comprehensive research acumen is further highlighted by his contributions to understanding hypoxia-induced epithelial-to-mesenchymal transitions and innovative cancer therapies, underscoring his significant impact on advancing medical science.
Awards and Recognition
Prof. Liang Tingbo has garnered numerous prestigious awards and recognitions throughout his illustrious career. He was honored as a Yangtze River Scholar by the Ministry of Education of China in 2011 and has been named a National Distinguished Young Scholar. His exceptional contributions were recognized with the First Class Institutional Scientific Advance Award from the Ministry of Education in 2013 and the First Class Zhejiang Scientific Advance Award in 2019. Prof. Liang has also received the Wu-Janssen Medical Award in 2019 and was designated a Zhejiang High-Level Healthcare Expert in 2010. His accolades include the Zhejiang Youth Scientific Award and multiple honors from Zhejiang University, such as the Qiushi Scholar and Zhejiang 151 Scholar First Level. These awards reflect his profound impact and leadership in hepatobiliary and pancreatic surgery and liver transplantation.
Conclusion
Prof. Liang Tingbo is an outstanding candidate for the Best Researcher Award due to his exceptional academic and professional achievements, extensive research contributions, and significant leadership roles. His impressive track record of research funding, influential publications, and prestigious awards strongly supports his candidacy. Addressing areas such as broader research impact and interdisciplinary collaboration could further enhance his contributions to the field.
Publications Top Notes
- The Role of Adjuvant Transcatheter Arterial Chemoembolization Following Repeated Curative Resection/Ablation for Hepatocellular Carcinoma with Early Recurrence: A Propensity Score Matching Analysis
- Authors: Huang, K., Qian, T., Chen, W., Ma, T., Liang, T.
- Year: 2024
- Journal: BMC Cancer
- Volume: 24(1)
- Page: 620
- TFPI from Erythroblasts Drives Heme Production in Central Macrophages Promoting Erythropoiesis in Polycythemia
- Authors: Ma, J.-K., Su, L.-D., Feng, L.-L., Liang, T., Lu, X.-J.
- Year: 2024
- Journal: Nature Communications
- Volume: 15(1)
- Article Number: 3976
- Risk Factors for Post-Operative Portal Vein Stenosis in Pediatric Liver Transplantation: A Single Center Case-Control Study
- Authors: Qian, Y., Zhang, W., Wang, W., Bai, X., Liang, T.
- Year: 2024
- Journal: Pediatric Surgery International
- Volume: 40(1)
- Page: 113
- ALYREF-JunD-SLC7A5 Axis Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epitranscriptome-Metabolism Reprogramming and Immune Evasion
- Authors: Meng, Q., Xie, Y., Sun, K., Zhang, Q., Liang, T.
- Year: 2024
- Citations: 1
- Journal: Cell Death Discovery
- Volume: 10(1)
- Article Number: 97
- Deciphering Extracellular Vesicles Protein Cargo in Pancreatic Cancer
- Authors: Hong, Y., Yang, J., Liu, X., Liang, T., Bai, X.
- Year: 2024
- Journal: Biochimica et Biophysica Acta – Reviews on Cancer
- Volume: 1879(5)
- Article Number: 189142
- Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer
- Authors: Huang, S., Yang, J., Xie, T., Liang, T., Bai, X.
- Year: 2024
- Journal: Advanced Science
- Volume: 11(28)
- Article Number: 2401845
- The Cancer Antioxidant Regulation System in Therapeutic Resistance
- Authors: Gu, X., Mu, C., Zheng, R., Zhang, Q., Liang, T.
- Year: 2024
- Journal: Antioxidants
- Volume: 13(7)
- Article Number: 778
- Incidence, Management and Outcomes in Hepatic Artery Complications After Pediatric Liver Transplantation: Protocol of the Retrospective, International, Multicentre HEPATIC Registry
- Authors: Li, W., van der Doef, H.P.J., Wildhaber, B.E., Hartog, H., Bokkers, R.P.H.
- Year: 2024
- Journal: BMJ Open
- Volume: 14(6)
- Article Number: e081933
- Comparison of Outcomes with Stapler Versus Hand-Sewn Closure of the Pancreatic Stump Following Minimally Invasive Distal Pancreatectomy: A Retrospective Cohort Study
- Authors: Qian, T., Huang, K., Chen, W., Ma, T., Liang, T.
- Year: 2024
- Journal: Journal of Pancreatology
- Volume: 7(2)
- Pages: 106–110
- Universal Antifungal Prophylaxis Effectively Prevents Fungal Bloodstream Infection in Pediatric Liver Transplant Recipients: A Retrospective Real-World Study
- Authors: Wang, W., Wang, Y., Zhang, Y., Zhang, Q., Liang, T.
- Year: 2024
- Journal: International Journal of Infectious Diseases
- Volume: 143
- Article Number: 107003